The European Medicines Agency Friday recommended approval of a third swine flu vaccine.

The agency said Celvapan from Baxter International Inc. (BAX) should be granted marketing authorization by the European Commission.

Commission approval is expected shortly, the agency said.

The European Medicines Agency Sept. 25 recommended approval of swine flu vaccines from GlaxoSmithKline PLC (GSK.LN) and Novartis AG (NOVN.VX).

Company Web site: www.emea.europa.eu

-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com